首页> 外国专利> RECOMBINANT PLASMID DNA PESG, METHOD OF PREPARING RECOMBINANT PLASMID DNA PESG AND STRAIN OF BACTERIUM ESCHERICHIA COLI CONTAINING RECOMBINANT PLASMID DNA PESG USED FOR PREPARING THE HYBRID PROTEIN CONSISTING OF 485 AMINO ACIDS SHOWING ANTIGENIC PROPERTIES OF HUMAN VIRUS T-CELLULAR LEUKOSIS OF THE FIRST TYPE

RECOMBINANT PLASMID DNA PESG, METHOD OF PREPARING RECOMBINANT PLASMID DNA PESG AND STRAIN OF BACTERIUM ESCHERICHIA COLI CONTAINING RECOMBINANT PLASMID DNA PESG USED FOR PREPARING THE HYBRID PROTEIN CONSISTING OF 485 AMINO ACIDS SHOWING ANTIGENIC PROPERTIES OF HUMAN VIRUS T-CELLULAR LEUKOSIS OF THE FIRST TYPE

机译:重组质粒DNA PESG,重组质粒DNA PESG的制备方法和含有重组质粒DNA PESG的大肠杆菌菌株,用于制备显示人病毒T型细胞抗原性的485个氨基酸的杂交蛋白

摘要

FIELD: biotechnology, genetic engineering. SUBSTANCE: invention relates to methods for detection of human virus T-cellular leukosis of the first type (HTLV-1). Invention involves preparing recombinant plasmid DNA providing high level of hybrid env-protein HTLV-1 production showing antigenic properties and preparing the strain-producer of the protein indicated. Plasmid pESG is obtained by fusion of plasmid pVR-291 fragment encoding E. coli β-galacosidase, two polylinkers, start replication region and gene determining resistance to ampicillin with plasmid pBEI fragment containing the sequence for env-protein HTLV-1. E. coli cells were transformed with the obtained plasmid and the strain GKV/pESG producing hybrid protein and containing specific virus-specific sequences of the gene env HTLV-1 is selected. Yield of protein showing antigenic properties of HTLV-1 at culturing the strain GKV/pESG is 200-350 mg/1 l cell suspension. EFFECT: improved method of plasmid preparing, increased yield of protein. 3 cl, 3 dwg
机译:领域:生物技术,基因工程。发明领域本发明涉及用于检测第一类人病毒T细胞白血病(HTLV-1)的方法。本发明涉及制备重组质粒DNA,该重组质粒DNA提供高水平的显示抗原特性的杂合env-蛋白HTLV-1,并制备所述蛋白的菌株-生产者。质粒pESG是通过将编码大肠杆菌β-半乳糖苷酶的质粒pVR-291片段,两个多接头,起始复制区和对氨苄青霉素的基因确定抗性与含有环境蛋白HTLV-1序列的质粒pBEI片段融合而获得的。用获得的质粒转化大肠杆菌细胞,并选择产生杂交蛋白并含有env HTLV-1基因的特定病毒特异性序列的菌株GKV / pESG。在培养菌株GKV / pESG时显示HTLV-1抗原特性的蛋白质产量为200-350 mg / 1 l细胞悬液。效果:改进了质粒制备方法,提高了蛋白质产量。 3 cl,3 dwg

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号